Chimerix, Inc.
CMRX
$8.54
-$0.01-0.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -34.57% | -85.98% | -99.57% | -99.88% | -99.04% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -34.57% | -85.98% | -99.57% | -99.88% | -99.04% |
| Cost of Revenue | 9.21% | 2.74% | 0.14% | -3.28% | -5.67% |
| Gross Profit | -9.41% | -4.08% | -80.27% | -73.99% | -67.40% |
| SG&A Expenses | -7.71% | -16.95% | 15.45% | 8.12% | 6.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.77% | -2.43% | 3.53% | -0.83% | -3.08% |
| Operating Income | -5.91% | 1.44% | -61.52% | -53.66% | -48.83% |
| Income Before Tax | -7.66% | 1.67% | -146.93% | -147.03% | -147.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.66% | 1.53% | -146.94% | -147.04% | -147.68% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.66% | 1.53% | -146.94% | -147.04% | -147.68% |
| EBIT | -5.91% | 1.44% | -61.52% | -53.66% | -48.83% |
| EBITDA | -5.91% | 1.44% | -61.63% | -53.75% | -48.92% |
| EPS Basic | -6.30% | 2.63% | -146.06% | -146.35% | -147.20% |
| Normalized Basic EPS | -8.72% | 0.65% | -67.59% | -48.92% | -35.99% |
| EPS Diluted | -6.41% | 2.40% | -146.34% | -146.65% | -147.51% |
| Normalized Diluted EPS | -8.72% | 0.65% | -67.55% | -48.89% | -35.95% |
| Average Basic Shares Outstanding | 1.25% | 1.12% | 1.09% | 1.13% | 1.20% |
| Average Diluted Shares Outstanding | 1.25% | 1.12% | 1.04% | 1.07% | 1.15% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |